Uiip Agreement

2. Flu consultation toolkit. Consulted on health.gov.on.ca/en/pro/programs/publichealth/flu/uiip/docs/flu_uiip_illness_handout_2015-16_en.PDF The College`s Administering Injections Practice Tool contains important information on training and registration requirements. Pharmacists can also refresh their practical knowledge by referring to their UIIP agreement and faQs from the Ministry of Health and Long-Term Care, which manages the program. Influenza vaccination will be significant this fall, given the co-production potential of COVID-19. Influenza prevention will be important not only to protect the individual health and health of families and communities, but also to protect and mitigate the effects on our health care system. Of the approximately 15,500 Part A pharmacists currently admitted to university, 65% are trained and registered for injection administration. Influenza vaccination can begin as soon as an influenza vaccine is available to all people living, working or schooling in Ontario from six months of age, especially high-risk groups and those who are able to transmit influenza. Figure 20. Number of reported laboratory-confirmed influenza cases, Ontario, 1991/1992 – 2016/2017. Pharmacists have been allowed to administer influenza vaccines since October 2012. Pharmacists participating in the UIIP may also administer the FluMist vaccine® to patients aged 5 to 17 years.

Patients outside this age group may receive the flumist vaccine ® publicly funded by their family physician. 3. Factors affecting reported diseases in Ontario www.publichealthontario.ca/en/eRepository/Factors-reportable-diseases-Ontario-1991-2016.pdf See below information on the Ontario Ministry`s General Influenza Vaccination Program (IUIP), which applies to the 2020/2021 flu season. Each year, the IUPI offers a free flu vaccine to everyone living, working or schooling in Ontario from six months of age. Pharmacists play an important role in promoting the well-being of patients and promoting a healthier community. This includes educating patients about current evidence-based immunization practices. In this diagram, you can determine who you can turn to for certain UIIP-related questions. β “cell culture-based” refers to how the flu vaccine is produced. Flucelvax® Quad is a mammalian cell-based QIV licensed for use in Canada in people 9 years of age and older. Egg and cell-based IVQs offer protection against four strains of influenza and are available in UIIP 2020/2021. Each of the available products can be used in the age group for which they are listed.

±Severe component of a vaccine can be a potential allergen. This table identifies the most common allergens. The National Advisory Committee on Immunization (ENAI) stresses that egg allergy is not a contraindication to influenza vaccination and that people with allergies can be vaccinated against influenza at the full dose of an age-appropriate product. Return vials containing residual doses to PHU or OGPMSS (for Toronto customers) as a waste. 1. The flu. Viewed: www.ontario.ca/page/flu-facts#section-1 3rd source of data: MOHLTC, iPHIS database, extracted from Public Health Ontario at [2013/03/07] for 1991-2004 data; [data from 16.05.2017/05.2016] for the 2005-2016 situation; [09.09.2010] for pH1N1 account for the 2009-2010 season; [03.09.2009] for pH1N1 account for the 2008-2009 season; [2011/08/10] for seasonal influenza counts for the 2008-2009 and 2009-2010 seasons.

About admin